Systemic amyloidosis: an aggressive evolution in a patient with relapsing polychondritis and monoclonal gammopathy of undetermined significance (MGUS) undergoing peritoneal dialysis
Autopsy Case Reports · 2024 · 14 · e2024518
DOI: 10.4322/acr.2024.518 ↗Kurz gefasst
Fallbericht in der Zeitschrift Autopsy Case Reports, 2024. Verfasst von Thiago Cavalcanti Matos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Universidade de São Paulo (USP), Faculdade de Medicina, Hospital das Clínicas, Serviço de Reumatologia, São Paulo, SP, Brasil. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Herein, we report the case of primary amyloidosis with multi-organ involvement in a female patient in her 50s. The patient had a history of relapsing polychondritis, chronic kidney disease, and monoclonal gammopathy of undetermined significance (MGUS). The clinical manifestations included neuropathic pain, sensorimotor polyneuropathy, intrahepatic cholestatic liver injury, gastrointestinal symptoms, dysautonomia, and myocardial thickening. Initial histologic evaluations of the abdominal fat pad aspirate and bone marrow biopsy were negative for amyloid deposition. However, due to a high index of suspicion, a second bone marrow biopsy was performed, confirming the presence of the amyloid protein. Given the patient's complex medical history, other types of amyloidosis, such as AA amyloidosis, AL amyloidosis, and ß2-microglobulin amyloidosis, should also be considered as differential diagnoses. The type of amyloid protein was subsequently identified through laser microdissection of amyloid fibrils followed by liquid chromatography-tandem mass spectrometry as AL-lambda (amyloid light-chain) amyloidosis. The patient presented unfavorable evolution, with progressive dysautonomia, being admitted to the ICU, culminating in refractory circulatory shock, and undergoing an empirical broad-spectrum antibiotic therapy. After a few days, she presented pulseless ventricular tachycardia, culminating in her death, before undergoing specific treatment. This article highlights the crucial role of precise identification in guiding appropriate therapeutic strategies for this complex, yet potentially severe, diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universidade de São Paulo (USP), Faculdade de Medicina, Hospital das Clínicas, Serviço de Reumatologia, São Paulo, SP, Brasil.
- Universidade de São Paulo (USP), Faculdade de Medicina de Ribeirão Preto, Hospital das Clínicas, Serviço de Hematologia, Ribeirão Preto, SP, Brasil.
ORCID-Profile: Thiago Cavalcanti Matos, William George Giusti Fischer, Rosa Maria Rodrigues Pereira, Andre Silva Franco
Zitieren
APA
Matos, T. C., Fischer, W. G. G., Pereira, R. M. R., & Franco, A. S. (2024). Systemic amyloidosis: an aggressive evolution in a patient with relapsing polychondritis and monoclonal gammopathy of undetermined significance (MGUS) undergoing peritoneal dialysis. Autopsy Case Reports, 14, e2024518. https://doi.org/10.4322/acr.2024.518
Vancouver
Matos TC, Fischer WGG, Pereira RMR, Franco AS. Systemic amyloidosis: an aggressive evolution in a patient with relapsing polychondritis and monoclonal gammopathy of undetermined significance (MGUS) undergoing peritoneal dialysis. Autopsy Case Reports. 2024;14:e2024518. doi:10.4322/acr.2024.518
BibTeX
@article{Matos2024,
author = {Matos, Thiago Cavalcanti and Fischer, William George Giusti and Pereira, Rosa Maria Rodrigues and Franco, Andre Silva},
title = {Systemic amyloidosis: an aggressive evolution in a patient with relapsing polychondritis and monoclonal gammopathy of undetermined significance (MGUS) undergoing peritoneal dialysis},
journal = {Autopsy Case Reports},
year = {2024},
volume = {14},
pages = {e2024518},
doi = {10.4322/acr.2024.518}
}
EUVIMED